Landmark BioVentures AG
Overview
Landmark BioVentures AG is an integrated biotech hub-and-spoke company that operates as an entrepreneurial investment firm, co-founding and supporting a nexus of startups to develop first-in-class therapeutics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Massalia Therapeutics | May 2025 | Seed | Lead |
| Duhn Therapeutics | Oct 2024 | Strategic | Co-investor |
| Kekkan Biologics | - | Accelerator | Lead |
| Elikya Therapeutics | - | Seed | Co-investor |
Key People
Gary Brandam
Co-founder and Chief Operating Officer
Mehdi Chelbi
Co-Founder
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
